4 diciembre 2014
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication. A NIH-funded study finds that almost 40 percent of people with first-episode psychosis in community mental health clinics across the country might benefit from medication treatment changes.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/0HBG76ECZ4U/141204074305.htm
